Sign In
Buy ACT
Advisorshares Vice Etf Earnings Calls
| Release date | Nov 05, 2025 |
| EPS estimate | $1.12 |
| EPS actual | $1.12 |
| Revenue estimate | 315.616M |
| Revenue actual | 311.455M |
| Revenue Surprise | -1.32% |
| Release date | Jul 30, 2025 |
| EPS estimate | $1.11 |
| EPS actual | $1.15 |
| EPS Surprise | 3.60% |
| Revenue estimate | 310.258M |
| Revenue actual | 304.617M |
| Revenue Surprise | -1.82% |
| Release date | Apr 30, 2025 |
| EPS estimate | $1.12 |
| EPS actual | $1.10 |
| EPS Surprise | -1.79% |
| Revenue estimate | 302.236M |
| Revenue actual | 306.891M |
| Revenue Surprise | 1.54% |
| Release date | Feb 04, 2025 |
| EPS estimate | $1.02 |
| EPS actual | $1.09 |
| EPS Surprise | 6.86% |
| Revenue estimate | 309.302M |
| Revenue actual | 301.776M |
| Revenue Surprise | -2.43% |
Last 4 Quarters for Advisorshares Vice Etf
Below you can see how ACT performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 04, 2025 |
| Price on release | $33.61 |
| EPS estimate | $1.02 |
| EPS actual | $1.09 |
| EPS surprise | 6.86% |
| Date | Price |
|---|---|
| Jan 29, 2025 | $33.92 |
| Jan 30, 2025 | $33.96 |
| Jan 31, 2025 | $33.78 |
| Feb 03, 2025 | $33.40 |
| Feb 04, 2025 | $33.61 |
| Feb 05, 2025 | $34.10 |
| Feb 06, 2025 | $34.14 |
| Feb 07, 2025 | $33.91 |
| Feb 10, 2025 | $33.95 |
| 4 days before | -0.91% |
| 4 days after | 1.01% |
| On release day | 1.46% |
| Change in period | 0.0884% |
| Release date | Apr 30, 2025 |
| Price on release | $35.79 |
| EPS estimate | $1.12 |
| EPS actual | $1.10 |
| EPS surprise | -1.79% |
| Date | Price |
|---|---|
| Apr 24, 2025 | $35.49 |
| Apr 25, 2025 | $34.86 |
| Apr 28, 2025 | $35.16 |
| Apr 29, 2025 | $35.50 |
| Apr 30, 2025 | $35.79 |
| May 01, 2025 | $36.57 |
| May 02, 2025 | $37.32 |
| May 05, 2025 | $36.56 |
| May 06, 2025 | $36.24 |
| 4 days before | 0.85% |
| 4 days after | 1.26% |
| On release day | 2.18% |
| Change in period | 2.11% |
| Release date | Jul 30, 2025 |
| Price on release | $34.42 |
| EPS estimate | $1.11 |
| EPS actual | $1.15 |
| EPS surprise | 3.60% |
| Date | Price |
|---|---|
| Jul 24, 2025 | $35.03 |
| Jul 25, 2025 | $35.23 |
| Jul 28, 2025 | $35.11 |
| Jul 29, 2025 | $35.26 |
| Jul 30, 2025 | $34.42 |
| Jul 31, 2025 | $34.76 |
| Aug 01, 2025 | $35.14 |
| Aug 04, 2025 | $35.36 |
| Aug 05, 2025 | $35.90 |
| 4 days before | -1.74% |
| 4 days after | 4.30% |
| On release day | 0.99% |
| Change in period | 2.48% |
| Release date | Nov 05, 2025 |
| Price on release | $35.93 |
| EPS estimate | $1.12 |
| EPS actual | $1.12 |
| Date | Price |
|---|---|
| Oct 30, 2025 | $35.50 |
| Oct 31, 2025 | $35.72 |
| Nov 03, 2025 | $35.90 |
| Nov 04, 2025 | $36.48 |
| Nov 05, 2025 | $35.93 |
| Nov 06, 2025 | $36.74 |
| Nov 07, 2025 | $37.00 |
| Nov 10, 2025 | $37.40 |
| Nov 11, 2025 | $37.62 |
| 4 days before | 1.21% |
| 4 days after | 4.70% |
| On release day | 2.25% |
| Change in period | 5.97% |
Advisorshares Vice Etf Earnings Call Transcript Summary of Q3 2025
Enact reported a strong Q3 2025 driven by disciplined execution, solid credit performance and active capital management. Adjusted operating income was $166 million ($1.12/share) and adjusted ROE was 13%. Insurance in-force rose to $272 billion and new insurance written totaled over $14 billion. Management increased 2025 capital return guidance to approximately $500 million (repurchases + dividends) and returned $136 million in the quarter. The company closed a new $435 million five-year revolving credit facility, executed additional CRT/reinsurance transactions (including a forward quota share ceding ~34% of 2027 new insurance written and a post-quarter excess-of-loss cover providing ~$170 million of protection for part of 2027), and reported a PMIERs sufficiency ratio of 162% ($1.9 billion above requirement). Credit metrics remain healthy (risk-weighted average FICO 746, RW avg LTV 93%), delinquencies increased modestly on seasonal trends (new delinquencies up to 13k; total delinquencies 23.4k) but overall credit performance remains strong. Investment yield on new money exceeds 5%, and expense discipline allowed management to lower 2025 expense guidance to ~$219 million (ex-reorg). Moody’s upgraded multiple ratings and A.M. Best raised the outlook to positive. Management emphasized balance sheet strength, prudent underwriting and continued technology investments (Rate360, AI) to support pricing, efficiency and growth.
